Brokerages Set Veradigm Inc. (NASDAQ:MDRX) Price Target at $12.00

Shares of Veradigm Inc. (NASDAQ:MDRX) have been given a consensus rating of “Hold” by the five research firms that are covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $12.00.

Separately, StockNews.com initiated coverage on Veradigm in a research note on Friday. They set a “hold” rating for the company.

Institutional Trading of Veradigm

Institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in Veradigm by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock valued at $149,754,000 after purchasing an additional 95,291 shares in the last quarter. Tyro Capital Management LLC acquired a new position in Veradigm during the first quarter worth about $9,055,000. Meadow Creek Wealth Advisors LLC purchased a new stake in Veradigm during the 1st quarter valued at about $83,000. Finally, Innealta Capital LLC acquired a new stake in Veradigm in the 2nd quarter valued at about $38,000.

Veradigm Price Performance

MDRX stock opened at $9.40 on Tuesday. Veradigm has a 52-week low of $5.01 and a 52-week high of $13.51. The company’s 50-day simple moving average is $9.51 and its 200-day simple moving average is $9.19.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.